AFP and hepatocellular carcinoma: AFP, an oncofetal glycoprotein discovered decades ago, has also been used as a serum and gene expression marker to evaluate hepatocyte regeneration activity closely related to concurrent hepatic necroinflammation or damage predisposing the liver to progression to advanced fibrosis, cirrhosis, or HCC [34].